This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 2.14% to $10.52 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.19% to 25,067.80 and Dow Jones Industrial Average falling 1.13% to 48,941.90.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 48.83% below its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. (VNDA) rose 8.00% to $7.56, Fortress Biotech Inc. (FBIO) rose 2.15% to $2.38, and Viking Therapeutics Inc. (VKTX) rose 5.87% to $31.76.
Trading volume (282,208) eclipsed its 50-day average volume of 246,695.
Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-04-26 1721ET

CRBP

SBIO

LABU

IBBQ

Corbus Pharmaceuticals Holdings Inc. (CRBP) saw its stock rise 2.14% to $10.52 on Monday, despite a challenging trading session for the overall market, with the NASDAQ down 0.19% and the Dow Jones down 1.13%. This marks the third consecutive day of gains for Corbus, although it remains 48.83% below its 52-week high of $20.56. In comparison, competitors like Vanda Pharmaceuticals, Fortress Biotech, and Viking Therapeutics outperformed Corbus with gains of 8.00%, 2.15%, and 5.87%, respectively. Trading volume was 282,208, surpassing the 50-day average of 246,695.

MarketWatch Automated

Corbus Pharma

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

NASDAQ Composite Index

Dow Jones Industrial Average

Vanda Pharma

Fortress Biotech

Viking Therap

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains